Social and gender inequity on overall survival and access to deep brain stimulation in Parkinson disease patients in Colombia
Objective: Describe discrepancies on survival and access to DBS in PD in Colombia by gender and affiliation regime. Background: Lower socioeconomic status (SES) has been…Beta LFP Power Change After Levodopa Intake in Parkinson’s Disease Patients with Chronic Sensing-Enabled DBS Systems
Objective: To study the relationship between oscillatory beta activity in the subthalamic nucleus (STN) and the intake of dopaminergic medication in a group of Parkinson’s…Response to Levodopa in Parkinson´s Disease Over Time. A 4-year Follow-up Study.
Objective: The aim of the present study was to analyze the response to levodopa in Parkinson´s disease (PD) patients with motor fluctuations followed up for…Use of the Dysphagia Handicap Index (DHI) patient reported outcomes measure in Parkinson disease and cervical dystonia
Objective: Objective: To demonstrate the value of using the DHI in movement disorders clinics. Background: Background: Dysphagia has a negative effect on work, leisure, and…Resolving missing data from the MDS-UPDRS: implications for telemedicine
Objective: The aim of this study was to determine imputation accuracy for total-sum and item-specific MDS-UPDRS Part III (Motor Examination) scores in remote administration. Background:…Cost-effectiveness of Lee Silverman Voice Treatment LOUD (LSVT®) versus NHS Speech and Language Therapy versus control for dysarthria in Parkinson’s disease: An economic evaluation alongside the PD COMM trial
Objective: We evaluated the cost effectiveness of two speech and language therapy techniques compared with no therapy in people with Parkinson's disease who have problems…MER length as a predictor of motor and non-motor outcomes of STN DBS in Parkinson’s disease
Objective: To test whether the length of the subthalamic nucleus (STN) in microelectrode recording (MER) can predict the 6-month motor and non-motor outcomes of DBS…Measuring the heterogeneity of disease progression in Parkinson’s disease with multimodal clinical milestones over 10 years in the DeNoPa cohort
Objective: To provide a reference of individual Parkinson’s disease (PD) progression by assessing multimodal milestones over 10 years (y) in patients of the DeNoPa cohort.…Parkinsonism in sjogren disease
Objective: explain the cause of parkinsonism in Sjogren's syndrome Background: Sjogren's syndrome (SS) may be associated with various pathologies of the central nervous system. It…Effects of intermittent theta burst stimulation over primary motor cortex on functional connectivity in Parkinson’s disease patients
Objective: To explore functional effect of intermittent theta burst stimulation (iTBS) protocol over primary motor cortex (M1) in Parkinson’s disease (PD) patients. Background: PD is…
- « Previous Page
- 1
- …
- 235
- 236
- 237
- 238
- 239
- …
- 436
- Next Page »